Stay updated on Atezolizumab vs Durvalumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page displays a 403 Forbidden error with a minimal header instead of the study record content. This indicates an access issue rather than a substantive update to the page's materials.
    Difference
    18%
    Check dated 2026-09-21T22:24:53.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6 on the page footer, indicating a software release; no study details or results appear to be altered.
    Difference
    0.0%
    Check dated 2026-08-31T16:44:12.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    A funding attribution line indicating a 2019 U.S. NIH grant/contract was added. This addition provides funding source context but does not alter study details or eligibility.
    Difference
    0.0%
    Check dated 2026-08-24T16:36:03.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.5, replacing the previous v3.6.4, reflecting a minor update to the page version.
    Difference
    0.0%
    Check dated 2026-08-10T10:38:36.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4 in the site metadata, replacing the previous v3.6.3. This change reflects a software release and does not alter study information or data.
    Difference
    0.0%
    Check dated 2026-07-27T06:24:43.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor maintenance update to the page with no substantive content changes.
    Difference
    0.0%
    Check dated 2026-07-05T14:33:04.000Z thumbnail image

Stay in the know with updates to Atezolizumab vs Durvalumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.